Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 1,316 |
| Other current assets | 31 |
| TOTAL | $1,347 |
| Non-Current Assets | |
| Investments And Advances | 99,978 |
| TOTAL | $99,978 |
| Total Assets | $101,325 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 4 |
| Accounts payable and accrued liabilities | 27 |
| TOTAL | $121 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 98,051 |
| TOTAL | $98,051 |
| Total Liabilities | $98,171 |
| Shareholders' Equity | |
| Shares Outstanding, K | 12,855 |
| Retained earnings | -41 |
| TOTAL | $5,000 |
| Total Liabilities And Equity | $103,171 |